Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
143.97B
Market cap143.97B
Price-Earnings ratio
19.27
Price-Earnings ratio19.27
Dividend yield
6.84%
Dividend yield6.84%
Average volume
37.78M
Average volume37.78M
High today
$25.50
High today$25.50
Low today
$24.76
Low today$24.76
Open price
$24.96
Open price$24.96
Volume
49.30M
Volume49.30M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.11
52 Week low$23.11

Stock Snapshot

With a market cap of 143.97B, Pfizer(PFE) trades at $25.21. The stock has a price-to-earnings ratio of 19.27 and currently yields dividends of 6.84%.

During the trading session on 2026-07-28, Pfizer(PFE) shares reached a daily high of $25.50 and a low of $24.76. At a current price of $25.21, the stock is +1.8% higher than the low and still -1.1% under the high.

Trading volume for Pfizer(PFE) stock has reached 49.3M, versus its average volume of 37.78M.

The stock's 52-week range extends from a low of $23.11 to a high of $28.75.

The stock's 52-week range extends from a low of $23.11 to a high of $28.75.

PFE News

TipRanks 5h
Pfizer Fine Tunes Ibuzatrelvir Tablet in Completed Phase 1 Study

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

Investing.com 7h
Pfizer shares may move 3% around Aug. 4 earnings release - Investing.com

...

Pfizer shares may move 3% around Aug. 4 earnings release - Investing.com
TipRanks 10h
Pfizer: Hold Rating Reiterated as Analyst Keeps $28 Price Target Unchanged Amid Balanced Pipeline Prospects and LOE Headwinds

In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer, with a price target of $28.00. Claim 55% Off TipRanks Unlo...

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

Simply Wall St 2d
Is Pfizer Undervalued On Its FDA Priority Review In Prostate Cancer?

Pfizer (PFE) is back in focus after the FDA accepted a Priority Review for its supplemental New Drug Application for TALZENNA plus XTANDI in metastatic castrati...

Is Pfizer Undervalued On Its FDA Priority Review In Prostate Cancer?
Nasdaq 3d
Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.

Key Points Pfizer is a large and well-respected pharmaceutical company. Pfizer has been facing headwinds, leaving investors worried about the dividend. The b...

Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.
Simply Wall St 3d
Pfizer Stock Leads 3 AI Healthcare Names Worth A Closer Look

With markets fixated on geopolitics, energy prices, and shifting inflation signals, many investors are looking for themes tied to long term structural change ra...

Pfizer Stock Leads 3 AI Healthcare Names Worth A Closer Look
TipRanks 4d
Pfizer Advances New Obesity Shot With Early Stage Trial of PF-08653945

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

TipRanks 4d
Pfizer’s PF-08057418 Clears Phase 1 Safety Milestone, Offering a Quiet Boost to Pipeline Confidence

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

TipRanks 4d
Pfizer’s VICTORIE Study Shines Light on Cancer Clot Care and Real World Costs

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

Simply Wall St 5d
How Investors May Respond To Pfizer Prostate Cancer Combo Drug Label Expansion Push

Earlier this week, Pfizer announced that the FDA accepted for Priority Review a supplemental application for TALZENNA plus XTANDI in men with HRR gene‑altered m...

How Investors May Respond To Pfizer Prostate Cancer Combo Drug Label Expansion Push

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.